I wanted to sell at one point, expecting value to drop like a rock due to sharply declining sales of Covid vaccines. But they’ve been investing heavily in other areas, especially in those where revolutionary development was triggered by mNRA... — read more 

Last quarter, Ken Griffin's Citadel and Israel Englander's Millennium Management both bought Pfizer (PFE 0.78%) stock. Investing in Pfizer might look like a questionable move as shares are down nearly 30% over the last three years and the stock has... — read more 

Its stock is currently trading at approximately 32% discount to its fair value estimate. It is big, diverse and known, and most importantly it will hold on to its patents until 2028. I think it may actually be a good medium-time investment. One... — read more 

It paid off short-term during pandemics, but it doesn’t have a sound business model. I held on to a very few stocks, more out of curiosity than anything else. Now lets see how their plan to sell directly to customers in order to compensate for... — read more 

Considering that COVID-19 vaccine sales are far, far below expected, is Pfizer still a safe stock to keep/buy? I've noticed the company's been in a cost-cutting mode for a while now, and in my opinion, that's never a good sign. A good company with... — read more 

Pfizer is a good dividend stock, if that's what you're after. Its dividend yield of 4.52 percent is among the best options out there. It is especially good to buy now when it is significantly undervalued. The stock is worth around $50 and is... — read more 

I'm wondering how much collaboration with Clear Creek Bio or plans to form a company with Roivant Sciences to sell a medicine for ulcerative colitis - will "mitigate" the serious decline in sales of Covid products. When I bought the shares... — read more 

PFE is one of the safe bets for the long run. While the demand for the COVID-19 vaccine is dropping, the company still has the Paxlovid pill to push its numbers up. Additionally, PFE is compensating by acquiring other companies that are boosting its... — read more 

Pfizer on track to post best monthly gain in nearly three decades https://seekingalpha.com/news/3775524-pfizer-on-track-to-post-best-monthly-gain-in-nearly-three-decades

I don't have much money to spend and I'm just getting into investing. The usual suspects are way out of my league, so I'm trying to find something I can spend 2k on that's relatively safe and will provide me with at least modest gains. Pfizer seems... — read more